Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WPRT
11101
Westport Fuel Systems
WPRT
$35M
| $172K | ﹤0.01% |
46,231
-38,120
| -45% | -$156K |
|
11102
CALL
Zevia
ZVIA
$104M
| $171K | ﹤0.01% |
79,100
-50,000
| -39% | -$164K |
|
|
GB
11103
PUT
DELISTED
Global Blue Group Holding
GB
| $171K | ﹤0.01% |
23,200
-200
| -0.9% | -$1.45K |
|
|
GDL
11104
GDL Fund
GDL
$91.9M
| $171K | ﹤0.01% |
20,727
+1,874
| +10% | +$15.5K |
|
|
SRTA
11105
CALL
Strata Critical Medical Inc
SRTA
$528M
| $171K | ﹤0.01% |
62,500
+39,800
| +175% | +$143K |
|
|
BORR
11106
CALL
Borr Drilling
BORR
$1.37B
| $171K | ﹤0.01% |
+77,900
| New | +$235K |
|
|
ERH
11107
Allspring Utilities & High Income Fund
ERH
$100M
| $170K | ﹤0.01% |
15,417
+3,344
| +28% | +$36.8K |
|
11108
CALL
First Trust STOXX European Select Dividend Income Fund
FDD
$929M
| $170K | ﹤0.01% |
+12,500
| New | +$157K |
|
|
ASM
11109
Avino Silver & Gold Mines
ASM
$1.27B
| $169K | ﹤0.01% |
91,804
-31,986
| -26% | -$43.6K |
|
|
MHF
11110
Western Asset Municipal High Income Fund
MHF
$152M
| $169K | ﹤0.01% |
22,783
+11,577
| +103% | +$84.5K |
|
11111
Neurogene
NGNE
$732M
| $169K | ﹤0.01% |
14,405
-60,373
| -81% | -$1.05M |
|
11112
CALL
Vuzix
VUZI
$219M
| $169K | ﹤0.01% |
82,600
-62,900
| -43% | -$206K |
|
11113
Dare Bioscience
DARE
$14.2M
| $168K | ﹤0.01% |
58,164
+17,582
| +43% | +$54.6K |
|
11114
Zentalis Pharmaceuticals
ZNTL
$360M
| $168K | ﹤0.01% |
105,687
+61,707
| +140% | +$133K |
|
|
MHN
11115
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
| $168K | ﹤0.01% |
16,555
+3,849
| +30% | +$40.1K |
|
11116
PUT
BuzzFeed
BZFD
$103M
| $168K | ﹤0.01% |
78,800
-94,000
| -54% | -$225K |
|
11117
PUT
Harmonic Inc
HLIT
$1.31B
| $168K | ﹤0.01% |
17,500
-12,100
| -41% | -$133K |
|
11118
Cosan
CSAN
$2.78B
| $168K | ﹤0.01% |
+32,098
| New | +$169K |
|
|
SVC
11119
PUT
Service Properties Trust
SVC
$1.02B
| $167K | ﹤0.01% |
12,820
+1,540
| +14% | +$20.9K |
|
11120
PIMCO Corporate & Income Opportunity Fund
PTY
$2.5B
| $167K | ﹤0.01% |
11,546
-46,594
| -80% | -$678K |
|
11121
Design Therapeutics
DSGN
$946M
| $167K | ﹤0.01% |
43,223
+5,911
| +16% | +$28.2K |
|
|
MRDN
11122
Meridian Holdings Inc
MRDN
$176M
| $167K | ﹤0.01% |
7,057
+349
| +5% | +$8.47K |
|
11123
Assembly Biosciences
ASMB
$694M
| $166K | ﹤0.01% |
17,414
-4,040
| -19% | -$52.8K |
|
11124
Angi Inc
ANGI
$204M
| $166K | ﹤0.01% |
10,777
+7,800
| +262% | +$133K |
|
11125
Telos
TLS
$358M
| $166K | ﹤0.01% |
69,769
+43,972
| +170% | +$135K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.